Jubilant HollisterStier Signs Manufacturing Agreement with Eli Lilly for COVID-19 Therapeutic Bamlanivimab
Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, recently announced that...
Recipharm signs manufacturing agreement with Enzymatica
Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science...
Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch...
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell...
T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse...
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply
Samsung Biologics and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under...
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First...
BioNTech SE announced the signing of a share purchase agreement with Novartis AG, Basel /...
GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050
GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and...
Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Memo Therapeutics and Northway Biotech collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody...
Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract...
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-1
Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s...
